Concepts (232)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Premature | 32 | 2025 | 175 | 5.650 |
Why?
|
| Bronchopulmonary Dysplasia | 18 | 2024 | 27 | 5.110 |
Why?
|
| Infant, Premature, Diseases | 9 | 2021 | 45 | 2.950 |
Why?
|
| Oxygen Inhalation Therapy | 7 | 2025 | 57 | 2.540 |
Why?
|
| Infant, Newborn | 43 | 2025 | 1283 | 2.520 |
Why?
|
| Apnea | 5 | 2017 | 30 | 1.800 |
Why?
|
| Oximetry | 7 | 2025 | 47 | 1.790 |
Why?
|
| Infant | 27 | 2024 | 1491 | 1.460 |
Why?
|
| Gestational Age | 9 | 2021 | 178 | 1.230 |
Why?
|
| Oxygen | 6 | 2022 | 313 | 1.220 |
Why?
|
| Sleep Apnea, Obstructive | 2 | 2017 | 54 | 1.050 |
Why?
|
| Child Restraint Systems | 3 | 2017 | 5 | 0.980 |
Why?
|
| Blood Gas Monitoring, Transcutaneous | 2 | 2024 | 4 | 0.950 |
Why?
|
| Length of Stay | 3 | 2017 | 776 | 0.920 |
Why?
|
| Carbon Dioxide | 2 | 2024 | 81 | 0.920 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2022 | 13 | 0.790 |
Why?
|
| Bradycardia | 4 | 2017 | 32 | 0.780 |
Why?
|
| Ventilator Weaning | 2 | 2011 | 19 | 0.760 |
Why?
|
| Home Care Services, Hospital-Based | 2 | 2020 | 5 | 0.740 |
Why?
|
| Intensive Care Units, Neonatal | 7 | 2025 | 75 | 0.720 |
Why?
|
| Caffeine | 3 | 2017 | 47 | 0.700 |
Why?
|
| Feeding Methods | 1 | 2019 | 8 | 0.650 |
Why?
|
| Ambulatory Care | 2 | 2024 | 303 | 0.650 |
Why?
|
| Enteral Nutrition | 1 | 2019 | 54 | 0.620 |
Why?
|
| Monitoring, Physiologic | 3 | 2024 | 149 | 0.620 |
Why?
|
| Catheterization, Central Venous | 1 | 2019 | 84 | 0.600 |
Why?
|
| Birth Weight | 2 | 2022 | 81 | 0.600 |
Why?
|
| Premature Birth | 4 | 2023 | 108 | 0.590 |
Why?
|
| Neuromuscular Diseases | 2 | 2017 | 20 | 0.590 |
Why?
|
| Humans | 48 | 2025 | 59374 | 0.580 |
Why?
|
| Craniofacial Abnormalities | 1 | 2017 | 26 | 0.560 |
Why?
|
| Central Nervous System Stimulants | 2 | 2017 | 63 | 0.560 |
Why?
|
| Term Birth | 1 | 2016 | 7 | 0.540 |
Why?
|
| Down Syndrome | 1 | 2017 | 47 | 0.530 |
Why?
|
| Retrospective Studies | 15 | 2023 | 6070 | 0.530 |
Why?
|
| Monitoring, Ambulatory | 1 | 2017 | 56 | 0.520 |
Why?
|
| Patient Discharge | 7 | 2022 | 490 | 0.520 |
Why?
|
| Home Care Services | 3 | 2025 | 97 | 0.510 |
Why?
|
| Hypoxia | 2 | 2014 | 112 | 0.510 |
Why?
|
| Asthma | 2 | 2017 | 460 | 0.500 |
Why?
|
| Child, Preschool | 13 | 2024 | 1792 | 0.500 |
Why?
|
| Respiration | 2 | 2024 | 88 | 0.480 |
Why?
|
| Quality of Life | 2 | 2020 | 1137 | 0.470 |
Why?
|
| Health Care Costs | 1 | 2017 | 202 | 0.470 |
Why?
|
| Body Weight | 2 | 2020 | 368 | 0.450 |
Why?
|
| Respiratory Aspiration | 1 | 2013 | 5 | 0.440 |
Why?
|
| Respiratory Mechanics | 2 | 2017 | 57 | 0.440 |
Why?
|
| Deglutition | 1 | 2013 | 17 | 0.440 |
Why?
|
| Child | 14 | 2024 | 4186 | 0.430 |
Why?
|
| Practice Guidelines as Topic | 2 | 2019 | 705 | 0.420 |
Why?
|
| Female | 26 | 2025 | 30720 | 0.420 |
Why?
|
| Equipment Failure | 1 | 2013 | 63 | 0.410 |
Why?
|
| Eating | 1 | 2013 | 130 | 0.410 |
Why?
|
| Male | 23 | 2025 | 27743 | 0.410 |
Why?
|
| Posture | 1 | 2013 | 127 | 0.400 |
Why?
|
| Patient Readmission | 2 | 2017 | 420 | 0.390 |
Why?
|
| Professional Practice | 1 | 2011 | 22 | 0.380 |
Why?
|
| Social Determinants of Health | 2 | 2025 | 122 | 0.350 |
Why?
|
| Hospitalization | 2 | 2023 | 1290 | 0.350 |
Why?
|
| Patient Safety | 1 | 2013 | 237 | 0.340 |
Why?
|
| Infant Equipment | 1 | 2010 | 2 | 0.340 |
Why?
|
| Parents | 3 | 2024 | 367 | 0.330 |
Why?
|
| Risk Factors | 7 | 2021 | 4986 | 0.290 |
Why?
|
| Receptors, IgG | 1 | 2007 | 35 | 0.290 |
Why?
|
| Trachea | 3 | 2017 | 91 | 0.280 |
Why?
|
| Pseudomonas aeruginosa | 1 | 2007 | 100 | 0.270 |
Why?
|
| Pneumonia, Bacterial | 1 | 2007 | 88 | 0.270 |
Why?
|
| Logistic Models | 4 | 2015 | 1234 | 0.270 |
Why?
|
| Boston | 3 | 2021 | 245 | 0.260 |
Why?
|
| Randomized Controlled Trials as Topic | 2 | 2020 | 677 | 0.250 |
Why?
|
| Infant, Extremely Low Birth Weight | 2 | 2016 | 6 | 0.240 |
Why?
|
| Air Pollution, Indoor | 1 | 2024 | 35 | 0.230 |
Why?
|
| Emergency Service, Hospital | 1 | 2012 | 1022 | 0.220 |
Why?
|
| Time Factors | 3 | 2025 | 3615 | 0.220 |
Why?
|
| Severity of Illness Index | 3 | 2017 | 1479 | 0.220 |
Why?
|
| Pediatrics | 3 | 2017 | 241 | 0.210 |
Why?
|
| Multivariate Analysis | 2 | 2016 | 902 | 0.200 |
Why?
|
| Prospective Studies | 3 | 2021 | 3067 | 0.200 |
Why?
|
| United States | 8 | 2022 | 7425 | 0.200 |
Why?
|
| Cannula | 1 | 2022 | 25 | 0.200 |
Why?
|
| Polysomnography | 2 | 2021 | 55 | 0.190 |
Why?
|
| Respiratory Tract Diseases | 1 | 2021 | 34 | 0.190 |
Why?
|
| Reference Values | 2 | 2013 | 326 | 0.190 |
Why?
|
| Nutrition Policy | 1 | 2021 | 39 | 0.180 |
Why?
|
| Adolescent Development | 1 | 2021 | 15 | 0.180 |
Why?
|
| Lung | 2 | 2021 | 920 | 0.180 |
Why?
|
| Tracheomalacia | 2 | 2017 | 5 | 0.170 |
Why?
|
| Respiratory System Agents | 1 | 2020 | 6 | 0.170 |
Why?
|
| Child Development | 1 | 2021 | 79 | 0.170 |
Why?
|
| Qualitative Research | 1 | 2024 | 619 | 0.170 |
Why?
|
| Multicenter Studies as Topic | 1 | 2020 | 130 | 0.170 |
Why?
|
| Body Mass Index | 2 | 2021 | 831 | 0.170 |
Why?
|
| Parenteral Nutrition, Total | 1 | 2019 | 27 | 0.160 |
Why?
|
| Infant, Extremely Premature | 1 | 2019 | 35 | 0.160 |
Why?
|
| Catheterization, Peripheral | 1 | 2019 | 46 | 0.160 |
Why?
|
| Respiration Disorders | 1 | 2019 | 23 | 0.160 |
Why?
|
| Drug Utilization | 1 | 2020 | 208 | 0.150 |
Why?
|
| Cohort Studies | 2 | 2016 | 2375 | 0.150 |
Why?
|
| Respiration, Artificial | 2 | 2023 | 292 | 0.150 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 2379 | 0.150 |
Why?
|
| Surveys and Questionnaires | 4 | 2024 | 2516 | 0.150 |
Why?
|
| Milk, Human | 1 | 2019 | 87 | 0.150 |
Why?
|
| Hypertension, Pulmonary | 2 | 2010 | 92 | 0.150 |
Why?
|
| Mothers | 1 | 2021 | 256 | 0.140 |
Why?
|
| Outpatients | 3 | 2023 | 137 | 0.140 |
Why?
|
| Infant Care | 1 | 2016 | 18 | 0.140 |
Why?
|
| Esophagoplasty | 1 | 2016 | 4 | 0.130 |
Why?
|
| Esophageal Atresia | 1 | 2016 | 9 | 0.130 |
Why?
|
| Tracheoesophageal Fistula | 1 | 2016 | 4 | 0.130 |
Why?
|
| New England | 2 | 2017 | 267 | 0.130 |
Why?
|
| Cost Savings | 1 | 2017 | 53 | 0.130 |
Why?
|
| Thoracotomy | 1 | 2016 | 44 | 0.130 |
Why?
|
| Anastomotic Leak | 1 | 2016 | 33 | 0.130 |
Why?
|
| Anastomosis, Surgical | 1 | 2016 | 107 | 0.130 |
Why?
|
| Infant, Low Birth Weight | 2 | 2015 | 56 | 0.130 |
Why?
|
| Analgesics, Opioid | 1 | 2021 | 483 | 0.130 |
Why?
|
| Hospital Costs | 1 | 2016 | 119 | 0.130 |
Why?
|
| Saliva | 1 | 2016 | 100 | 0.130 |
Why?
|
| Tracheobronchomalacia | 1 | 2015 | 1 | 0.120 |
Why?
|
| Quality Improvement | 1 | 2019 | 417 | 0.120 |
Why?
|
| Bronchi | 1 | 2015 | 82 | 0.120 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 692 | 0.120 |
Why?
|
| Age Factors | 3 | 2021 | 1504 | 0.110 |
Why?
|
| Sucking Behavior | 1 | 2013 | 1 | 0.110 |
Why?
|
| Barium | 1 | 2013 | 5 | 0.110 |
Why?
|
| Health Status | 1 | 2016 | 425 | 0.110 |
Why?
|
| Inpatients | 1 | 2016 | 291 | 0.110 |
Why?
|
| Diuretics | 1 | 2013 | 59 | 0.110 |
Why?
|
| Databases, Factual | 1 | 2016 | 814 | 0.110 |
Why?
|
| Equipment Safety | 1 | 2013 | 20 | 0.100 |
Why?
|
| Prevalence | 1 | 2016 | 1252 | 0.100 |
Why?
|
| New York | 1 | 2013 | 134 | 0.100 |
Why?
|
| Postoperative Complications | 2 | 2016 | 1204 | 0.100 |
Why?
|
| Respiratory Function Tests | 2 | 2024 | 189 | 0.100 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2013 | 168 | 0.100 |
Why?
|
| Needs Assessment | 1 | 2013 | 187 | 0.100 |
Why?
|
| Morbidity | 2 | 2022 | 113 | 0.100 |
Why?
|
| Equipment Design | 1 | 2013 | 329 | 0.100 |
Why?
|
| Tachykinins | 1 | 2011 | 9 | 0.100 |
Why?
|
| Complement C3a | 1 | 2011 | 7 | 0.100 |
Why?
|
| Vital Signs | 1 | 2011 | 11 | 0.090 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2011 | 29 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2013 | 746 | 0.090 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2011 | 34 | 0.090 |
Why?
|
| Pulmonary Medicine | 1 | 2011 | 40 | 0.090 |
Why?
|
| Ambulatory Care Facilities | 1 | 2011 | 101 | 0.090 |
Why?
|
| Interleukin-17 | 1 | 2011 | 88 | 0.090 |
Why?
|
| Tracheotomy | 1 | 2010 | 7 | 0.090 |
Why?
|
| Guideline Adherence | 1 | 2013 | 292 | 0.090 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 1027 | 0.080 |
Why?
|
| Contraindications | 1 | 2010 | 46 | 0.080 |
Why?
|
| Tracheostomy | 2 | 2023 | 36 | 0.080 |
Why?
|
| Treatment Outcome | 3 | 2017 | 5281 | 0.080 |
Why?
|
| Incidence | 1 | 2013 | 1238 | 0.080 |
Why?
|
| Referral and Consultation | 2 | 2024 | 405 | 0.080 |
Why?
|
| Lung Diseases | 1 | 2010 | 170 | 0.080 |
Why?
|
| Receptor, Anaphylatoxin C5a | 1 | 2007 | 2 | 0.070 |
Why?
|
| Complement C5a | 1 | 2007 | 5 | 0.070 |
Why?
|
| Capillary Permeability | 1 | 2007 | 15 | 0.070 |
Why?
|
| Cytokines | 2 | 2011 | 915 | 0.070 |
Why?
|
| Phagocytes | 1 | 2007 | 50 | 0.070 |
Why?
|
| Pseudomonas Infections | 1 | 2007 | 51 | 0.070 |
Why?
|
| Leukocytes | 1 | 2007 | 97 | 0.070 |
Why?
|
| Massachusetts | 2 | 2024 | 2019 | 0.070 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 187 | 0.070 |
Why?
|
| Phagocytosis | 1 | 2007 | 260 | 0.060 |
Why?
|
| Babesiosis | 1 | 2006 | 11 | 0.060 |
Why?
|
| Transfusion Reaction | 1 | 2006 | 44 | 0.060 |
Why?
|
| Adult | 3 | 2024 | 15679 | 0.060 |
Why?
|
| Cell Movement | 1 | 2007 | 428 | 0.060 |
Why?
|
| Hospital Mortality | 1 | 2010 | 841 | 0.060 |
Why?
|
| Survival Rate | 1 | 2007 | 801 | 0.060 |
Why?
|
| Longitudinal Studies | 2 | 2021 | 1189 | 0.060 |
Why?
|
| Partial Pressure | 1 | 2024 | 9 | 0.060 |
Why?
|
| Tertiary Care Centers | 1 | 2024 | 100 | 0.060 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2024 | 57 | 0.060 |
Why?
|
| Communication Barriers | 1 | 2024 | 56 | 0.060 |
Why?
|
| Chronic Disease | 2 | 2021 | 717 | 0.050 |
Why?
|
| Adolescent | 3 | 2021 | 5835 | 0.050 |
Why?
|
| Child Health Services | 1 | 2024 | 61 | 0.050 |
Why?
|
| Ventilators, Mechanical | 1 | 2023 | 29 | 0.050 |
Why?
|
| Child Day Care Centers | 1 | 2022 | 9 | 0.050 |
Why?
|
| Steroids | 1 | 2022 | 52 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2024 | 484 | 0.050 |
Why?
|
| Echocardiography | 1 | 2024 | 457 | 0.050 |
Why?
|
| Aftercare | 1 | 2021 | 69 | 0.050 |
Why?
|
| Insurance Coverage | 1 | 2022 | 99 | 0.050 |
Why?
|
| Vital Capacity | 1 | 2021 | 105 | 0.050 |
Why?
|
| Inflammation | 1 | 2007 | 1098 | 0.040 |
Why?
|
| Forced Expiratory Volume | 1 | 2021 | 193 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 193 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 1 | 2007 | 3231 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 527 | 0.040 |
Why?
|
| Societies | 1 | 2019 | 23 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 1559 | 0.040 |
Why?
|
| Mice | 2 | 2011 | 10294 | 0.040 |
Why?
|
| Registries | 1 | 2021 | 799 | 0.040 |
Why?
|
| Esophageal Stenosis | 1 | 2016 | 3 | 0.030 |
Why?
|
| Diverticulum | 1 | 2016 | 11 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2017 | 86 | 0.030 |
Why?
|
| Algorithms | 1 | 2021 | 974 | 0.030 |
Why?
|
| Postoperative Period | 1 | 2016 | 127 | 0.030 |
Why?
|
| Animals | 3 | 2011 | 19650 | 0.030 |
Why?
|
| Reoperation | 1 | 2016 | 272 | 0.030 |
Why?
|
| Mass Screening | 1 | 2020 | 648 | 0.030 |
Why?
|
| Recurrence | 1 | 2016 | 602 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2021 | 1925 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 327 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 2213 | 0.030 |
Why?
|
| Pneumonia | 1 | 2015 | 281 | 0.020 |
Why?
|
| Respiratory Syncytial Viruses | 1 | 2011 | 17 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2017 | 2338 | 0.020 |
Why?
|
| Young Adult | 1 | 2021 | 4272 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 145 | 0.020 |
Why?
|
| Models, Biological | 1 | 2016 | 1143 | 0.020 |
Why?
|
| Respiratory System Abnormalities | 1 | 2010 | 3 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 446 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 527 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2010 | 63 | 0.020 |
Why?
|
| Age Distribution | 1 | 2010 | 249 | 0.020 |
Why?
|
| Flow Cytometry | 1 | 2011 | 645 | 0.020 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 88 | 0.020 |
Why?
|
| Risk | 1 | 2010 | 364 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2010 | 94 | 0.020 |
Why?
|
| Hemodynamics | 1 | 2010 | 230 | 0.020 |
Why?
|
| Gene Expression | 1 | 2011 | 809 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 718 | 0.020 |
Why?
|
| Middle Aged | 1 | 2024 | 16312 | 0.020 |
Why?
|
| Surface-Active Agents | 1 | 2007 | 112 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2011 | 1997 | 0.020 |
Why?
|
| Babesia | 1 | 2006 | 1 | 0.020 |
Why?
|
| Prognosis | 1 | 2010 | 1597 | 0.020 |
Why?
|